Patent ID: 9102692
Filing Date: 2015-08-11
Classification: A61K,A61P,C07D,C07F

Abstract:
1. A method for treating a disorder, comprising administering a pharmaceutically effective amount of a composition comprising a compound represented by formula (I), or a pharmaceutically acceptable salt thereof to a patient in need of treatment of the disorder; wherein R 1 , R 2 , R 3 , and R 4 each independently represents the group listed below: R R R R R A represents a 5- to 10-membered heteroaryl ring or C R R n represents 1 to 3; R Z R R R R R R R R R R R R R R R R R R R group P is a halogen, C group Q is a halogen, C wherein the disorder is breast cancer, acute myelocytic leukemia, pancreatic cancer, bladder cancer, prostatic cancer, esophageal cancer, angiogenesis, stomach cancer, uterine body cancer, ovarian cancer, brain tumor, colon cancer, multiple myeloma, hepatocarcinoma, pulmonary cancer, or thyroid cancer.